Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma

作者: Ben Davidson , Martina Skrede , Ilvars Silins , Ie-Ming Shih , Claes G. Trope

DOI: 10.1002/CNCR.22918

关键词:

摘要: BACKGROUND. The authors recently reported on the role of cyclin E in differentiating ovarian/primary peritoneal carcinoma from malignant mesothelioma using gene expression arrays. In current study, they analyzed low-molecular weight (LMW) forms ovarian carcinoma, mesothelioma, and benign reactive effusions. METHODS. Cyclin protein was 98 effusions (72 carcinomas, 14 mesotheliomas, 12 specimens) immunoblotting. Sixty-two were studied further for immunohistochemistry. The correlations between clinical parameters, including chemotherapy response, analyzed. RESULTS. LMW identified 54 72 (75%) compared with 1 (7%) (8%) (P < .001). Their presence associated a higher percentage E-positive cells = .001) increased staining intensity LMW correlated shorter overall survival .021) progression-free .020). immunohistochemistry .026). No association response observed. CONCLUSIONS. LMW differentiated mesothelial not although it may be marker aggressive disease patients metastatic carcinoma. Cancer 2007. © 2007 American Society.

参考文章(31)
Giovanni Scambia, Valeria Masciullo, Bruna Pucci, Gabriella Ferrandina, Alessandro Sgambato, Carmen Pacilio, Juan Palazzo, Antonio Giordano, Arnaldo Carbone, Salvatore Mancuso, Achille Cittadini, Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Research. ,vol. 59, pp. 3790- 3794 ,(1999)
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, M. J. Thun, Cancer statistics, 2007. CA: A Cancer Journal for Clinicians. ,vol. 57, pp. 43- 66 ,(2007) , 10.3322/CANJCLIN.57.1.43
Daniel G. Rosen, Gong Yang, Michael T. Deavers, Anais Malpica, John J. Kavanagh, Gordon B. Mills, Jinsong Liu, Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma Cancer. ,vol. 106, pp. 1925- 1932 ,(2006) , 10.1002/CNCR.21767
Lilach Kleinberg, Vivi Ann Flørenes, Ilvars Silins, Kristiane Haug, Claes G. Trope, Jahn M. Nesland, Ben Davidson, Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma Cancer. ,vol. 109, pp. 228- 238 ,(2007) , 10.1002/CNCR.22426
Amit Deshpande, Peter Sicinski, Philip W Hinds, Cyclins and cdks in development and cancer: a perspective Oncogene. ,vol. 24, pp. 2909- 2915 ,(2005) , 10.1038/SJ.ONC.1208618
Khandan Keyomarsi, Susan L. Tucker, Thomas A. Buchholz, Matthew Callister, Ye Ding, Gabriel N. Hortobagyi, Isabelle Bedrosian, Christopher Knickerbocker, Wendy Toyofuku, Michael Lowe, Thaddeus W. Herliczek, Sarah S. Bacus, Cyclin E and Survival in Patients with Breast Cancer The New England Journal of Medicine. ,vol. 347, pp. 1566- 1575 ,(2002) , 10.1056/NEJMOA021153
Raffit Hassan, Tapan Bera, Ira Pastan, Mesothelin: A new target for immunotherapy Clinical Cancer Research. ,vol. 10, pp. 3937- 3942 ,(2004) , 10.1158/1078-0432.CCR-03-0801
Stephen A. Cannistra, Cancer of the Ovary New England Journal of Medicine. ,vol. 329, pp. 1550- 1559 ,(1993) , 10.1056/NEJM199311183292108
H. Blegen, N. Einhorn, K. Sjovall, A. Roschke, B. M. Ghadimi, L. M. Mcshane, B. Nilsson, K. Shah, T. Ried, G. Auer, Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas. International Journal of Gynecological Cancer. ,vol. 10, pp. 477- 487 ,(2000) , 10.1046/J.1525-1438.2000.00077.X
Li Sui, Youyi Dong, Masayuki Ohno, Katsuyoshi Sugimoto, Yuji Tai, Tamotsu Hando, Masaaki Tokuda, None, Implication of Malignancy and Prognosis of p27kip1, Cyclin E, and Cdk2 Expression in Epithelial Ovarian Tumors Gynecologic Oncology. ,vol. 83, pp. 56- 63 ,(2001) , 10.1006/GYNO.2001.6308